A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health- care news straight to your inbox. Subscribe here to receive future editions. President Donald Trump has been pressuring pharmaceutical companies to lower U.S. drug costs, and it may be starting to work – at least on AstraZeneca. Why now? Soriot's comments come two months after Trump signed a sweeping executive order that aims to renew a plan to lower U.S. drug costs by linking prices to significant ...